Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • HyperPFU™ high-fidelity DNA polymerase Guide

    2026-08-10

    HyperPFU™ high-fidelity DNA polymerase: Practical PCR Guide

    HyperPFU™ high-fidelity DNA polymerase is a recombinant proofreading DNA polymerase for PCR workflows where sequence accuracy, template difficulty, or amplicon length makes routine Taq-based amplification unsuitable. The enzyme combines 5′→3′ polymerase activity with 3′→5′ exonuclease proofreading activity and is supplied with a standard 5X HF Buffer.

    The HyperPFU™ high-fidelity DNA polymerase product dossier describes an enzyme concentration of 1,000 units/mL, blunt-ended PCR products, tolerance to various PCR inhibitors, and enhanced processivity. These specifications make it a candidate cloning and sequencing enzyme, an enzyme for long fragment PCR, and a possible high-throughput sequencing PCR enzyme when the specific assay is validated in the user’s laboratory.

    What This Product Solves

    Standard PCR can become unreliable when a target contains high GC content, repeated sequence, stable secondary structure, or a long distance between primers. Failure may appear as no detectable product, a weak band, multiple products, or sequence errors that are unacceptable for downstream cloning or sequence analysis. PCR amplification of GC-rich templates also commonly requires more attention to template quality, primer placement, and annealing conditions than routine amplification.

    HyperPFU is designed for this problem class rather than for universal replacement of every PCR enzyme. Its proofreading activity is intended to reduce copying errors, while the fused DNA-binding domain and reported processivity support amplification of difficult or long targets. The dossier reports an error rate more than 50-fold lower than Taq DNA polymerase and sixfold lower than Pyrococcus furiosus DNA polymerase. It also describes reaction progress as approximately 10 times quicker than Pfu polymerase. These are product-dossier claims and should be treated as starting expectations, not guaranteed performance for every template.

    Product architecture also determines the DNA ends. HyperPFU generates blunt-ended PCR products. That is appropriate for blunt-end cloning, sequence-verified inserts, and workflows that perform end repair before ligation. It is not the correct default choice for a protocol that specifically depends on 3′-A addition or a naturally generated sticky end.

    For related selection guidance, HyperPFU™ High-Fidelity DNA Polymerase: Practical PCR Guidance discusses the same long- and GC-rich-template use case. The companion Practical Guide: HyperPFU™ High-Fidelity DNA Polymerase in PCR is useful when the main decision is whether blunt-ended, high-fidelity product is compatible with the downstream cloning design.

    Protocol Parameters

    • Assay: Enzyme format and concentration; Value: 1,000 units/mL; Applicability: PCR setup and reagent calculation; Rationale: Use the stated stock concentration when converting the validated reaction volume and unit requirement into a pipetting scheme; Evidence basis: product dossier.
    • Assay: Reaction buffer; Value: supplied standard 5X HF Buffer; Applicability: difficult, long, or GC-rich DNA targets; Rationale: Use the supplied buffer as the initial reaction system rather than substituting a generic polymerase buffer, because the dossier identifies it as optimized for complex templates; Evidence basis: product dossier.
    • Assay: End structure; Value: blunt-ended PCR product; Applicability: blunt-end cloning, sequencing preparation, and end-repair workflows; Rationale: Confirm vector and library-preparation compatibility before amplification, since the product should not be expected to generate 3′-A overhangs or sticky ends; Evidence basis: product dossier and workflow interpretation.
    • Assay: Fidelity-sensitive amplification; Value: reported error rate over 50-fold lower than Taq and sixfold lower than Pfu; Applicability: sequence-accurate cloning and variant-sensitive PCR; Rationale: Proofreading is a reason to prefer this enzyme over a standard Taq workflow when sequence integrity is important; Evidence basis: product dossier, not an independently matched paper result.
    • Assay: Storage; Value: −20 °C; Applicability: reagent handling between experiments; Rationale: Return the enzyme to the recommended storage temperature after use and minimize unnecessary exposure to room temperature; Evidence basis: product dossier.
    • Assay: Per-reaction enzyme input; Value: follow the current product instructions and optimize around the validated starting amount; Applicability: new templates or unusually difficult amplicons; Rationale: The supplied dossier does not state a universal unit input, so a fixed amount should not be invented for all assays; Evidence basis: workflow recommendation.

    Workflow Setup and QC Checklist

    Before assembly

    1. Verify the target sequence, expected amplicon length, GC distribution, and primer orientation. Place primers in unique regions and check for strong self-complementarity or complementarity between the primer pair.
    2. Use clean template DNA with a measurable concentration. Inhibitor tolerance is useful for challenging samples, but it does not remove the need to control salts, residual alcohol, detergents, extraction reagents, or excess genomic material.
    3. Confirm the downstream end requirement. Select HyperPFU when blunt ends are acceptable, and choose a different strategy when the cloning vector requires 3′-A overhangs or a defined sticky end.

    Reaction assembly

    1. Thaw the 5X HF Buffer thoroughly, mix it without creating excessive foam, and keep the enzyme cold during setup. Prepare a master mix for replicate reactions to reduce pipetting variation.
    2. Add template last when practical, and include a no-template control. For a new target, include a known amplifiable control or a previously successful template so that reagent failure can be separated from target-specific failure.
    3. Use the supplied HF Buffer as the initial condition. Set denaturation, annealing, and extension conditions according to primer properties, amplicon length, and the current product protocol. Do not transfer a cycling program from Taq or Pfu without checking whether its extension assumptions are appropriate.

    Post-PCR QC

    1. Assess the reaction on an appropriate agarose gel or another validated sizing method. Record whether the product is absent, weak, single and correctly sized, or accompanied by nonspecific bands.
    2. For cloning, purify the intended product and confirm that the vector-end strategy matches a blunt-ended insert. For sequence-sensitive work, verify representative products by sequencing rather than assuming that a high-fidelity designation eliminates all errors.
    3. For high-throughput workflows, monitor batch-to-batch consistency with the same control template, primer set, and analysis threshold. Validate library yield and sequence quality in the complete workflow rather than evaluating the enzyme in isolation.

    Common Failure Modes and Fixes

    No visible or insufficient product

    Check template integrity, primer specificity, and the presence of inhibitors before changing multiple reaction variables. Rebuild the reaction with fresh buffer and enzyme, confirm the stock was stored at −20 °C, and compare with the no-template and control reactions. If the control works but the difficult target does not, review primer placement and test a controlled annealing-condition adjustment or a validated GC-enhancing additive.

    Multiple bands or a smear

    Non-specific amplification can result from poorly matched primer conditions, excessive template, excessive cycle exposure, or nonspecific priming. Recheck primer design, reduce template burden if the sample is concentrated or impure, and adjust annealing conditions systematically. Keep the enzyme and buffer constant while changing one variable at a time so the cause is identifiable.

    GC-rich target remains refractory

    Confirm that the template is not degraded or chemically inhibited, then inspect the target for extreme local GC content and stable repeats. Use the supplied HF Buffer as the baseline, optimize primer placement where possible, and evaluate a validated additive or alternative denaturation strategy only in a controlled comparison. A successful result for one GC-rich amplicon does not establish universal performance for all GC-rich sequences.

    Cloning fails despite a strong band

    The product may be correctly amplified but incompatible with the intended ligation chemistry. HyperPFU produces blunt-ended DNA, so a vector requiring 3′-A overhangs or sticky ends will need an appropriate end-conversion step or a different amplification strategy. Also check purification losses, insert-to-vector design, and whether the purified band is the intended product.

    Unexpected sequence changes

    Use clean template and primer stocks, minimize avoidable amplification burden, and sequence independent clones or reaction products when accuracy matters. Mixed starting templates, contamination, primer mispriming, and selection during cloning can all complicate interpretation; proofreading activity alone is not a substitute for sequence confirmation.

    Scope and Limitations

    This guide is based on the supplied product dossier and laboratory workflow practice; no directly matched paper evidence was provided for this product in the present brief. Therefore, the reported comparisons with Taq and Pfu, the approximate speed statement, inhibitor tolerance, and suitability for long or GC-rich targets should be verified against the user’s own template and cycling system.

    The dossier does not provide a universal reaction recipe, enzyme units per reaction, primer concentration, template mass, or cycling program. Those values should come from the current manufacturer instructions and controlled assay optimization, not from assumptions based on another proofreading DNA polymerase. The enzyme is also not described as a reverse transcriptase, ligase, end-repair enzyme, or 3′-A-tailing enzyme; these functions should not be inferred from its PCR activity.

    Conclusion

    HyperPFU™ high-fidelity DNA polymerase is a practical starting choice when PCR requires proofreading, robust amplification of difficult DNA, or blunt-ended products. Use the supplied 5X HF Buffer, control template quality and contamination, optimize the cycling program for the specific amplicon, and verify the final product by sizing and sequencing as appropriate. Most importantly, confirm end chemistry before committing the product to cloning or library preparation, because blunt-ended output is a defining workflow constraint.